These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab. Khayat-Khoei M; Conway S; Rubinson DA; Jarolim P; Houtchens MK J Neurol; 2021 Oct; 268(10):3592-3594. PubMed ID: 33638680 [No Abstract] [Full Text] [Related]
43. Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction? Melgosa Ramos FJ; Estébanez Corrales A; Mateu Puchades A Med Clin (Barc); 2021 Nov; 157(10):506. PubMed ID: 34092400 [No Abstract] [Full Text] [Related]
44. In a search of a protective titer: Do we or do we not need to know? Baranova A; Chandhoke V; Makarova AV; Veytsman B Clin Transl Med; 2021 Dec; 11(12):e668. PubMed ID: 34898055 [TBL] [Abstract][Full Text] [Related]
45. Altered mental status and pronounced febrile response after second mRNA-1273 (Moderna) COVID-19 vaccine administration in a patient with previously documented COVID-19 infection. Hilaire PS; Tito E; Muthukumarasamy N; Schauer M BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34580129 [TBL] [Abstract][Full Text] [Related]
47. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Chiang TP; Connolly CM; Ruddy JA; Boyarsky BJ; Alejo JL; Werbel WA; Massie A; Christopher-Stine L; Garonzik-Wang J; Segev DL; Paik JJ Ann Rheum Dis; 2021 Oct; 80(10):1365-1366. PubMed ID: 34429320 [No Abstract] [Full Text] [Related]
48. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies. Greenberger LM; Saltzman LA; Senefeld JW; Johnson PW; DeGennaro LJ; Nichols GL Cancer Cell; 2021 Aug; 39(8):1031-1033. PubMed ID: 34331856 [No Abstract] [Full Text] [Related]
49. The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients. Levi R; Ubaldi L; Pozzi C; Angelotti G; Sandri MT; Azzolini E; Salvatici M; Savevski V; Mantovani A; Rescigno M Commun Med (Lond); 2021; 1(1):32. PubMed ID: 35072166 [TBL] [Abstract][Full Text] [Related]
50. Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naïve Subjects. Ghini V; Maggi L; Mazzoni A; Spinicci M; Zammarchi L; Bartoloni A; Annunziato F; Turano P Front Mol Biosci; 2022; 9():839809. PubMed ID: 35480886 [No Abstract] [Full Text] [Related]
51. Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction? Melgosa Ramos FJ; Estébanez Corrales A; Mateu Puchades A Med Clin (Engl Ed); 2021 Nov; 157(10):506. PubMed ID: 34697597 [No Abstract] [Full Text] [Related]
52. Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections. Corradini P; Gobbi G; de Braud F; Rosa J; Rusconi C; Apolone G; Carniti C Hemasphere; 2020 Jun; 4(3):e408. PubMed ID: 32647806 [No Abstract] [Full Text] [Related]
53. Covid-19: Antibody levels fall after second Pfizer dose, but protection against severe disease remains, studies indicate. Mahase E BMJ; 2021 Oct; 375():n2481. PubMed ID: 34635474 [No Abstract] [Full Text] [Related]
54. Muscle MRI is not sufficient to diagnose SARS-CoV-2 associated myositis. Finsterer J Med J Armed Forces India; 2022 Jan; 78(1):121-122. PubMed ID: 34908646 [No Abstract] [Full Text] [Related]
55. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. Tenforde MW; Olson SM; Self WH; Talbot HK; Lindsell CJ; Steingrub JS; Shapiro NI; Ginde AA; Douin DJ; Prekker ME; Brown SM; Peltan ID; Gong MN; Mohamed A; Khan A; Exline MC; Files DC; Gibbs KW; Stubblefield WB; Casey JD; Rice TW; Grijalva CG; Hager DN; Shehu A; Qadir N; Chang SY; Wilson JG; Gaglani M; Murthy K; Calhoun N; Monto AS; Martin ET; Malani A; Zimmerman RK; Silveira FP; Middleton DB; Zhu Y; Wyatt D; Stephenson M; Baughman A; Womack KN; Hart KW; Kobayashi M; Verani JR; Patel MM; ; MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):674-679. PubMed ID: 33956782 [TBL] [Abstract][Full Text] [Related]
56. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222 [TBL] [Abstract][Full Text] [Related]
57. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021. Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784 [TBL] [Abstract][Full Text] [Related]